Tumor-Agnostic Landscape with &lt;i&gt;HER2&lt;/i&gt; Amplification in Japan: Real-World Prevalence and Implications for Targeting &lt;i&gt;HER2&lt;/i&gt;. Here, ERBB2 is linked to neoplasm.